-
LAMP1 Controls CXCL10-CXCR3 Macrophage Polarization
2026-09-21
The 2024 International Immunopharmacology study identifies LAMP1 as a context-dependent regulator of CXCL10-CXCR3 signaling and macrophage polarization. Its combination of pharmacological antagonism, LAMP1 knockdown, autophagy analysis, and a poly(I:C)-induced lung injury model shows why CXCR3 responses can differ between inflammatory and non-inflammatory macrophage states.
-
SMYD2–miR-125b Control of RCC Drug Resistance
2026-09-21
This study identifies SMYD2 as both a prognostic marker and a functional driver of clear cell renal cell carcinoma, linking epigenetic regulation to miR-125b, DKK3, P-glycoprotein, and multidrug resistance. Its combined clinical, molecular, cellular, and xenograft design provides a framework for testing whether SMYD2 inhibition can improve responses to conventional anticancer drugs, including fluorouracil.
-
Rice Stripe Virus NS3 Rewires Host Signaling
2026-09-20
Zhuang et al. show that Rice stripe virus NS3 dynamically engages the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway to balance antiviral defense, tissue damage, pathogenicity, and vector transmission. The study provides a mechanistic model of virus–plant–planthopper co-survival in which NS3 abundance and phosphorylation state produce stage-dependent outcomes.
-
Dextromethorphan hydrobromide for Neuroprotection
2026-09-19
Build more reproducible excitotoxicity and ion-channel assays with Dextromethorphan hydrobromide, using concentration controls, orthogonal readouts, and solvent-aware handling. The workflow also shows how findings from structure-guided PDK4 inhibitor research can improve assay design without confusing metabolic-disease evidence with direct neuroprotection evidence.
-
Heparin Sodium as an HSPG Probe in Nanovesicle Assays
2026-09-18
Heparin sodium is best known as a glycosaminoglycan anticoagulant, but its structural relationship to heparan sulfate makes it a useful hypothesis-testing tool in nanovesicle uptake studies. This article connects coagulation controls with the HSPG-dependent Sertoli-cell findings reported for Cistanche deserticola nanovesicles.
-
IGF2BP3–FZD1/7 Drives TNBC Stemness and Resistance
2026-09-18
The reference study identifies IGF2BP3 as an m6A reader that stabilizes FZD1 and FZD7 transcripts, activates β-catenin signaling, and reinforces stem-like properties and carboplatin resistance in triple-negative breast cancer. Its findings suggest that disrupting the IGF2BP3–FZD1/7 axis may improve chemotherapy response, although the evidence remains preclinical and requires validation across models.
-
Calcitriol: From VDR Mechanism to Translation
2026-09-17
A mechanism-led guide to using Calcitriol as a translational research tool across VDR biology, endometrial decidualization, immune modulation, and Hedgehog signaling, with practical assay design and evidence boundaries.
-
RSV NS3 Phosphorylation Rewires Host Signaling
2026-09-17
Zhuang et al. show that Rice stripe virus NS3 uses stage-dependent self-interaction and phosphorylation to redirect the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway, balancing antiviral RNA interference, reactive oxygen species, programmed cell death, and transmission. The study provides a mechanistic model for co-survival across rice, the small brown planthopper vector, and related host systems.
-
Ceruletide: From CCK Signaling to Fibrosis Insight
2026-09-16
A translational framework for using Ceruletide, also known as Caerulein in many experimental contexts, to connect pancreatic injury modeling with mechanistic studies of stellate-cell activation, autophagy, and fibrosis.
-
Proteasome Inhibition and Thymic Regeneration
2026-09-16
The reference study identifies proteasome inhibition as an unexpected inducer of FOXN1 in murine and human thymic epithelial cells, linking proteostasis stress to thymic repair. Its findings position nitazoxanide as a pharmacological lead for testing thymic regeneration while also defining important safety and transferability questions for future studies.
-
OLIG2 Phosphorylation Drives Glioma Invasion via TGF-β
2026-09-15
Singh et al. showed that phosphorylation of the transcription factor OLIG2 helps determine whether glioma cells favor proliferation or invasion. The study identified TGFβ2 signaling as a mechanistic link between OLIG2 phosphorylation state and invasive behavior, providing a rationale for pathway-focused experiments in glioblastoma models.
-
Calpain Inhibitor I, ALLN: Practical Protocol Guide
2026-09-15
Calpain Inhibitor I, ALLN (SKU A2602) provides a defined inhibition profile for calpain I/II and cathepsin B/L, supporting controlled protease studies in apoptosis, inflammation, and ischemia-reperfusion workflows. It is intended for research use only, should be prepared in an appropriate organic solvent, and should not be used for diagnostic, therapeutic, or medical applications.
-
RSV NS3 Rewires Host Kinase Signaling
2026-09-14
Zhuang et al. show that Rice stripe virus NS3 uses stage-dependent phosphorylation and host kinase interactions to balance pathogenicity, plant survival, and vector transmission. The study identifies an OsSnRK3.25–OsCBL1/3–OsRBOHF signaling axis as a central control point linking calcium signaling, reactive oxygen species, programmed cell death, and antiviral RNA interference.
-
Docetaxel: Mechanism and Cancer Research Uses
2026-09-14
Docetaxel, also known as Taxotere, is a semisynthetic taxane that stabilizes microtubules and disrupts mitotic progression. Its documented research uses include cancer chemotherapy research, apoptosis induction in cancer cells, and xenograft studies, but experimental concentration and formulation data must not be treated as clinical dosing guidance.
-
Bergenin Targets γδT17 Cells in Psoriasis
2026-09-13
A 2026 Phytomedicine study identifies a PPARγ–PROX1 ubiquitination pathway through which bergenin suppresses pathogenic γδT17-cell activity and psoriasis-like inflammation. Its combination of immune profiling, metabolic analysis, protein-interaction assays, and chromatin measurements provides a useful framework for evaluating mechanism rather than relying on disease scores alone.